COVID-19 UPDATE: At GW Pharmaceuticals, our main concern is the well-being of our patients, healthcare partners, and employees.
Read More

EPIDIOLEX^® (cannabidiol) UPDATE: The DEA has confirmed that EPIDIOLEX (cannabidiol) is no longer scheduled.
Learn More

Home

About Us

Girl Smiling

GW is the global leader in developing cannabinoid-based medicines.

Healthcare Professionals

Boy and Mother Looking at Something

GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics.

Patients & Caregivers

Girl Blowing Bubbles

"GW's vision is to be the global leader in prescription cannabinoid medicines, developing and commercializing pharmaceutical products which address clear unmet needs." >

-Justin Gover,
Chief Executive Officer

Investors & Media

Arlo and his mother

Click here to view Investors Relations section. >

Careers

Boy Looking at Something

Join GW Pharmaceuticals where you can positively impact the lives of patients. >

Recent News

Girl Blowing Bubbles

May 01, 2020

GW Pharmaceuticals to Present at the Bank of America Healthcare Conference 2020